Clozapine 25 MG Oral Tablet [Clozaril] — RxCUI 104775
RxNorm drug concept · Semantic branded drug
RxCUI 104775
Semantic branded drug · SBD
● Current RxNorm concept 2 FDA products
2 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI104775
Official nameClozapine 25 MG Oral Tablet [Clozaril]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asClozaril 25 MG Oral Tablet
FDA products mapped2
Package NDCs mapped2
Reported Medicaid activity (SDUD)849 prescriptions · 11 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Clozapine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Clozapine is reserved for situations where other antipsychotics haven't provided enough relief. If you're taking it for schizophrenia, it means your care team determined that stand...
- Why am I on clozapine instead of a regular antipsychotic?
- This is genuinely one of the most important parts of being on clozapine. The medication can cause a dangerous drop in the white blood cells that fight infection — a condition calle...
- Why do I have to get blood tests so often?
🕸️ Concept Web — How Clozapine 25 MG Oral Tablet [Clozaril] Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Clozapine 25 MG Oral Tablet [Clozaril]
RxCUI 104775 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Clozapine
2626IN
-
Clozapine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Clozaril
216102BN
-
Clozaril
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Clozapine Oral Tablet
371602SCDF -
Clozapine Oral Product
1153930SCDG -
Clozapine Pill
1153931SCDG -
Clozapine Oral Tablet [Clozaril]
368910SBDF -
Clozaril Oral Product
1173714SBDG -
Clozaril Pill
1173715SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Clozapine Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Clozapine 25 MG Oral Tablet
197536SCD -
Clozapine 25 MG
315706SCDC -
Clozapine 25 MG [Clozaril]
563747SBDC
-
Clozapine 25 MG Oral Tablet
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Clozapine 25 MG Oral Tablet
SCD · 197536 -
Clozapine 25 MG
SCDC · 315706 -
Clozapine Oral Tablet
SCDF · 371602 -
Clozapine Oral Product
SCDG · 1153930 -
Clozapine Pill
SCDG · 1153931
Brand-Name Concepts
-
Clozapine 25 MG [Clozaril]
SBDC · 563747 -
Clozapine Oral Tablet [Clozaril]
SBDF · 368910 -
Clozaril Oral Product
SBDG · 1173714 -
Clozaril Pill
SBDG · 1173715 -
Clozaril
BN · 216102
📦 FDA Products & Package NDCs
2 products · 2 package NDCs
2 package NDCs map to RxCUI 104775 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 69809-0126-05 | 100 TABLET in 1 BOTTLE (69809-0126-5) | Clozaril | HLS Therapeutics (USA), Inc. | 2016-05-06 |
| 69809-0127-05 | 100 TABLET in 1 BOTTLE (69809-0127-5) | Clozaril | HLS Therapeutics (USA), Inc. | 2016-05-06 |
Observed labelers:
HLS Therapeutics (USA), Inc. (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.